nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Ceruletide—CCKAR—type 2 diabetes mellitus	0.0238	0.968	CrCbGaD
Nafarelin—GNRHR—Peptide GPCRs—MC4R—type 2 diabetes mellitus	0.00783	0.0354	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCKAR—type 2 diabetes mellitus	0.00543	0.0246	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—AGTR2—type 2 diabetes mellitus	0.00475	0.0215	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—EDNRB—type 2 diabetes mellitus	0.00455	0.0206	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GCGR—type 2 diabetes mellitus	0.00443	0.02	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—EDNRA—type 2 diabetes mellitus	0.00429	0.0194	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GRK5—type 2 diabetes mellitus	0.00408	0.0185	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GCGR—type 2 diabetes mellitus	0.00397	0.0179	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—type 2 diabetes mellitus	0.00365	0.0165	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—EDNRA—type 2 diabetes mellitus	0.00364	0.0165	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.0034	0.0154	CbGpPWpGaD
Nafarelin—GNRHR—Peptide GPCRs—CCR5—type 2 diabetes mellitus	0.00277	0.0125	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.00259	0.0117	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—CCKAR—type 2 diabetes mellitus	0.00259	0.0117	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.00247	0.0112	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CCR5—type 2 diabetes mellitus	0.00234	0.0106	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—type 2 diabetes mellitus	0.00231	0.0105	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—TRPC6—type 2 diabetes mellitus	0.00227	0.0103	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00224	0.0101	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—EDNRB—type 2 diabetes mellitus	0.00217	0.00979	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—HTR2C—type 2 diabetes mellitus	0.0021	0.0095	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00206	0.00931	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—EDNRA—type 2 diabetes mellitus	0.00204	0.00925	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—type 2 diabetes mellitus	0.00203	0.0092	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.00202	0.00915	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GHRL—type 2 diabetes mellitus	0.00199	0.00901	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRB—type 2 diabetes mellitus	0.00194	0.00876	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.00188	0.00851	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—type 2 diabetes mellitus	0.00188	0.0085	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—type 2 diabetes mellitus	0.00183	0.00827	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GCG—type 2 diabetes mellitus	0.00182	0.00824	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.00181	0.00819	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—RASGRP1—type 2 diabetes mellitus	0.00179	0.00811	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00179	0.00808	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—type 2 diabetes mellitus	0.00178	0.00806	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00171	0.00775	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—type 2 diabetes mellitus	0.00163	0.00737	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—type 2 diabetes mellitus	0.0016	0.00725	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—GNB3—type 2 diabetes mellitus	0.00157	0.0071	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AVP—type 2 diabetes mellitus	0.00155	0.00701	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.00154	0.00697	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.0015	0.00677	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00149	0.00673	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—EDN1—type 2 diabetes mellitus	0.00147	0.00667	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00146	0.00662	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.00143	0.00648	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GNB3—type 2 diabetes mellitus	0.0014	0.00635	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00139	0.00629	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—type 2 diabetes mellitus	0.00139	0.00627	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—type 2 diabetes mellitus	0.00139	0.00627	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00136	0.00615	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00135	0.00612	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00133	0.00601	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00133	0.006	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00133	0.00599	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00132	0.00597	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—type 2 diabetes mellitus	0.00132	0.00596	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.0013	0.0059	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00126	0.00571	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—AGT—type 2 diabetes mellitus	0.00122	0.00553	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.00117	0.00531	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.00116	0.00526	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.00116	0.00526	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.00115	0.00519	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.00114	0.00516	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—type 2 diabetes mellitus	0.00109	0.00495	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.00109	0.00494	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.00109	0.00491	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.00106	0.00481	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.00106	0.00479	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.00106	0.00478	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.00106	0.00478	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.00103	0.00466	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.00103	0.00464	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.00102	0.00463	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.00101	0.00456	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.001	0.00454	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.000993	0.00449	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.000993	0.00449	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.000976	0.00441	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.000966	0.00437	CbGpPWpGaD
Nafarelin—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000961	0.00127	CcSEcCtD
Nafarelin—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000958	0.00127	CcSEcCtD
Nafarelin—Palpitations—Gliclazide—type 2 diabetes mellitus	0.000955	0.00127	CcSEcCtD
Nafarelin—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000949	0.00126	CcSEcCtD
Nafarelin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000946	0.00125	CcSEcCtD
Nafarelin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000943	0.00125	CcSEcCtD
Nafarelin—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000936	0.00124	CcSEcCtD
Nafarelin—Anorexia—Glyburide—type 2 diabetes mellitus	0.000936	0.00124	CcSEcCtD
Nafarelin—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000934	0.00124	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.00093	0.0042	CbGpPWpGaD
Nafarelin—Rhinitis—Losartan—type 2 diabetes mellitus	0.000925	0.00123	CcSEcCtD
Nafarelin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.00092	0.00122	CcSEcCtD
Nafarelin—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00092	0.00122	CcSEcCtD
Nafarelin—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00092	0.00122	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.000919	0.00416	CbGpPWpGaD
Nafarelin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000919	0.00122	CcSEcCtD
Nafarelin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000919	0.00122	CcSEcCtD
Nafarelin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000918	0.00122	CcSEcCtD
Nafarelin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000916	0.00121	CcSEcCtD
Nafarelin—Asthenia—Glipizide—type 2 diabetes mellitus	0.000916	0.00121	CcSEcCtD
Nafarelin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000913	0.00121	CcSEcCtD
Nafarelin—Malnutrition—Metformin—type 2 diabetes mellitus	0.000904	0.0012	CcSEcCtD
Nafarelin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000903	0.0012	CcSEcCtD
Nafarelin—Weight increased—Ramipril—type 2 diabetes mellitus	0.000899	0.00119	CcSEcCtD
Nafarelin—GNRHR—G alpha (q) signalling events—PIK3R1—type 2 diabetes mellitus	0.000898	0.00406	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000895	0.00119	CcSEcCtD
Nafarelin—Vertigo—Valsartan—type 2 diabetes mellitus	0.000892	0.00118	CcSEcCtD
Nafarelin—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000885	0.00117	CcSEcCtD
Nafarelin—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000882	0.00117	CcSEcCtD
Nafarelin—Vertigo—Orlistat—type 2 diabetes mellitus	0.000881	0.00117	CcSEcCtD
Nafarelin—Palpitations—Valsartan—type 2 diabetes mellitus	0.000877	0.00116	CcSEcCtD
Nafarelin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000877	0.00116	CcSEcCtD
Nafarelin—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000876	0.00116	CcSEcCtD
Nafarelin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000873	0.00116	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.000873	0.00395	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.000871	0.00394	CbGpPWpGaD
Nafarelin—Acute coronary syndrome—Ramipril—type 2 diabetes mellitus	0.000868	0.00115	CcSEcCtD
Nafarelin—Palpitations—Orlistat—type 2 diabetes mellitus	0.000867	0.00115	CcSEcCtD
Nafarelin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000866	0.00115	CcSEcCtD
Nafarelin—Myocardial infarction—Ramipril—type 2 diabetes mellitus	0.000864	0.00114	CcSEcCtD
Nafarelin—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000856	0.00114	CcSEcCtD
Nafarelin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000854	0.00113	CcSEcCtD
Nafarelin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000854	0.00113	CcSEcCtD
Nafarelin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000853	0.00113	CcSEcCtD
Nafarelin—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000853	0.00113	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.000853	0.00386	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000853	0.00113	CcSEcCtD
Nafarelin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000852	0.00113	CcSEcCtD
Nafarelin—Convulsion—Orlistat—type 2 diabetes mellitus	0.00085	0.00113	CcSEcCtD
Nafarelin—Chest pain—Valsartan—type 2 diabetes mellitus	0.000845	0.00112	CcSEcCtD
Nafarelin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000845	0.00112	CcSEcCtD
Nafarelin—Myalgia—Valsartan—type 2 diabetes mellitus	0.000845	0.00112	CcSEcCtD
Nafarelin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000844	0.00112	CcSEcCtD
Nafarelin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000843	0.00112	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.000841	0.0038	CbGpPWpGaD
Nafarelin—Tension—Irbesartan—type 2 diabetes mellitus	0.000837	0.00111	CcSEcCtD
Nafarelin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000836	0.00111	CcSEcCtD
Nafarelin—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000835	0.00111	CcSEcCtD
Nafarelin—Myalgia—Orlistat—type 2 diabetes mellitus	0.000835	0.00111	CcSEcCtD
Nafarelin—Chest pain—Orlistat—type 2 diabetes mellitus	0.000835	0.00111	CcSEcCtD
Nafarelin—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000831	0.0011	CcSEcCtD
Nafarelin—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000829	0.0011	CcSEcCtD
Nafarelin—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000826	0.0011	CcSEcCtD
Nafarelin—Alopecia—Losartan—type 2 diabetes mellitus	0.000815	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000815	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000812	0.00108	CcSEcCtD
Nafarelin—Vomiting—Glipizide—type 2 diabetes mellitus	0.000811	0.00108	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.00081	0.00366	CbGpPWpGaD
Nafarelin—Oedema—Valsartan—type 2 diabetes mellitus	0.00081	0.00107	CcSEcCtD
Nafarelin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000808	0.00107	CcSEcCtD
Nafarelin—Rash—Glipizide—type 2 diabetes mellitus	0.000805	0.00107	CcSEcCtD
Nafarelin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000804	0.00107	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000803	0.00107	CcSEcCtD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3R1—type 2 diabetes mellitus	0.000803	0.00363	CbGpPWpGaD
Nafarelin—Oedema—Orlistat—type 2 diabetes mellitus	0.000801	0.00106	CcSEcCtD
Nafarelin—Headache—Glipizide—type 2 diabetes mellitus	0.000799	0.00106	CcSEcCtD
Nafarelin—Palpitations—Metformin—type 2 diabetes mellitus	0.000799	0.00106	CcSEcCtD
Nafarelin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000798	0.00106	CcSEcCtD
Nafarelin—Shock—Valsartan—type 2 diabetes mellitus	0.000797	0.00106	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000792	0.00358	CbGpPWpGaD
Nafarelin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000792	0.00105	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.000791	0.00357	CbGpPWpGaD
Nafarelin—Desmopressin—PTGS2—type 2 diabetes mellitus	0.000789	0.0321	CrCbGaD
Nafarelin—Tension—Losartan—type 2 diabetes mellitus	0.000788	0.00104	CcSEcCtD
Nafarelin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000787	0.00104	CcSEcCtD
Nafarelin—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000786	0.00104	CcSEcCtD
Nafarelin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000786	0.00104	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000785	0.00355	CbGpPWpGaD
Nafarelin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000785	0.00104	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000782	0.00353	CbGpPWpGaD
Nafarelin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00078	0.00103	CcSEcCtD
Nafarelin—Nervousness—Losartan—type 2 diabetes mellitus	0.00078	0.00103	CcSEcCtD
Nafarelin—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000774	0.00103	CcSEcCtD
Nafarelin—Anorexia—Valsartan—type 2 diabetes mellitus	0.000772	0.00102	CcSEcCtD
Nafarelin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000771	0.00102	CcSEcCtD
Nafarelin—Myalgia—Metformin—type 2 diabetes mellitus	0.00077	0.00102	CcSEcCtD
Nafarelin—Chest pain—Metformin—type 2 diabetes mellitus	0.00077	0.00102	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000769	0.00348	CbGpPWpGaD
Nafarelin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000766	0.00102	CcSEcCtD
Nafarelin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000766	0.00102	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000764	0.00345	CbGpPWpGaD
Nafarelin—Nausea—Glipizide—type 2 diabetes mellitus	0.000758	0.001	CcSEcCtD
Nafarelin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000757	0.001	CcSEcCtD
Nafarelin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000755	0.001	CcSEcCtD
Nafarelin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000754	0.001	CcSEcCtD
Nafarelin—Rash—Glimepiride—type 2 diabetes mellitus	0.000751	0.000995	CcSEcCtD
Nafarelin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00075	0.000995	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000749	0.00339	CbGpPWpGaD
Nafarelin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000748	0.000992	CcSEcCtD
Nafarelin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000748	0.000991	CcSEcCtD
Nafarelin—Headache—Glimepiride—type 2 diabetes mellitus	0.000746	0.000989	CcSEcCtD
Nafarelin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000744	0.000986	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000743	0.00336	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000738	0.000979	CcSEcCtD
Nafarelin—Oedema—Metformin—type 2 diabetes mellitus	0.000738	0.000978	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000737	0.00333	CbGpPWpGaD
Nafarelin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000735	0.000975	CcSEcCtD
Nafarelin—Insomnia—Valsartan—type 2 diabetes mellitus	0.000733	0.000972	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000729	0.000967	CcSEcCtD
Nafarelin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000728	0.000965	CcSEcCtD
Nafarelin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000726	0.000963	CcSEcCtD
Nafarelin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000726	0.000963	CcSEcCtD
Nafarelin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000726	0.000963	CcSEcCtD
Nafarelin—Shock—Metformin—type 2 diabetes mellitus	0.000726	0.000962	CcSEcCtD
Nafarelin—Insomnia—Orlistat—type 2 diabetes mellitus	0.000724	0.00096	CcSEcCtD
Nafarelin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000722	0.000958	CcSEcCtD
Nafarelin—Vertigo—Losartan—type 2 diabetes mellitus	0.000721	0.000956	CcSEcCtD
Nafarelin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000719	0.000953	CcSEcCtD
Nafarelin—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000713	0.000946	CcSEcCtD
Nafarelin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00071	0.000942	CcSEcCtD
Nafarelin—Palpitations—Losartan—type 2 diabetes mellitus	0.00071	0.000941	CcSEcCtD
Nafarelin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000707	0.000938	CcSEcCtD
Nafarelin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000705	0.000935	CcSEcCtD
Nafarelin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000705	0.000934	CcSEcCtD
Nafarelin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000704	0.000934	CcSEcCtD
Nafarelin—Anorexia—Metformin—type 2 diabetes mellitus	0.000703	0.000932	CcSEcCtD
Nafarelin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000701	0.000929	CcSEcCtD
Nafarelin—Alopecia—Ramipril—type 2 diabetes mellitus	0.000699	0.000927	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000698	0.00316	CbGpPWpGaD
Nafarelin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000696	0.000923	CcSEcCtD
Nafarelin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000696	0.000923	CcSEcCtD
Nafarelin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000695	0.000921	CcSEcCtD
Nafarelin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000693	0.000919	CcSEcCtD
Nafarelin—Constipation—Valsartan—type 2 diabetes mellitus	0.000693	0.000919	CcSEcCtD
Nafarelin—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000688	0.000913	CcSEcCtD
Nafarelin—Shock—Irbesartan—type 2 diabetes mellitus	0.000685	0.000908	CcSEcCtD
Nafarelin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000684	0.000906	CcSEcCtD
Nafarelin—Myalgia—Losartan—type 2 diabetes mellitus	0.000684	0.000906	CcSEcCtD
Nafarelin—Chest pain—Losartan—type 2 diabetes mellitus	0.000684	0.000906	CcSEcCtD
Nafarelin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000683	0.000906	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000681	0.00308	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000678	0.00307	CbGpPWpGaD
Nafarelin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000677	0.000898	CcSEcCtD
Nafarelin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000677	0.000897	CcSEcCtD
Nafarelin—Tension—Ramipril—type 2 diabetes mellitus	0.000676	0.000896	CcSEcCtD
Nafarelin—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000674	0.000894	CcSEcCtD
Nafarelin—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000673	0.000892	CcSEcCtD
Nafarelin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000673	0.000892	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000672	0.000891	CcSEcCtD
Nafarelin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000672	0.000891	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.00067	0.00303	CbGpPWpGaD
Nafarelin—Nervousness—Ramipril—type 2 diabetes mellitus	0.000669	0.000886	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000667	0.00302	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000665	0.003	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000664	0.003	CbGpPWpGaD
Nafarelin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000664	0.00088	CcSEcCtD
Nafarelin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000663	0.000878	CcSEcCtD
Nafarelin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000658	0.000872	CcSEcCtD
Nafarelin—Oedema—Losartan—type 2 diabetes mellitus	0.000655	0.000869	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000649	0.00294	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.000648	0.00293	CbGpPWpGaD
Nafarelin—Shock—Losartan—type 2 diabetes mellitus	0.000645	0.000855	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000644	0.00291	CbGpPWpGaD
Nafarelin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000644	0.000853	CcSEcCtD
Nafarelin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000641	0.00085	CcSEcCtD
Nafarelin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000638	0.000846	CcSEcCtD
Nafarelin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000636	0.000843	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000634	0.000841	CcSEcCtD
Nafarelin—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000633	0.00084	CcSEcCtD
Nafarelin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000633	0.000839	CcSEcCtD
Nafarelin—Constipation—Metformin—type 2 diabetes mellitus	0.000631	0.000836	CcSEcCtD
Nafarelin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000625	0.000829	CcSEcCtD
Nafarelin—Anorexia—Losartan—type 2 diabetes mellitus	0.000625	0.000828	CcSEcCtD
Nafarelin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000624	0.000828	CcSEcCtD
Nafarelin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000624	0.000827	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000624	0.00282	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000624	0.00282	CbGpPWpGaD
Nafarelin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000621	0.000823	CcSEcCtD
Nafarelin—Rash—Glyburide—type 2 diabetes mellitus	0.000619	0.000821	CcSEcCtD
Nafarelin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000619	0.00082	CcSEcCtD
Nafarelin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000619	0.00082	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000617	0.00279	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000617	0.00279	CbGpPWpGaD
Nafarelin—Headache—Glyburide—type 2 diabetes mellitus	0.000615	0.000816	CcSEcCtD
Nafarelin—Palpitations—Ramipril—type 2 diabetes mellitus	0.000608	0.000807	CcSEcCtD
Nafarelin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000605	0.000802	CcSEcCtD
Nafarelin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000603	0.0008	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000603	0.00273	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000599	0.00271	CbGpPWpGaD
Nafarelin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000597	0.000791	CcSEcCtD
Nafarelin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000596	0.000791	CcSEcCtD
Nafarelin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000595	0.000789	CcSEcCtD
Nafarelin—Insomnia—Losartan—type 2 diabetes mellitus	0.000593	0.000786	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000589	0.00266	CbGpPWpGaD
Nafarelin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000588	0.00078	CcSEcCtD
Nafarelin—Urticaria—Metformin—type 2 diabetes mellitus	0.000586	0.000777	CcSEcCtD
Nafarelin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000586	0.000777	CcSEcCtD
Nafarelin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000586	0.000777	CcSEcCtD
Nafarelin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000586	0.000777	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000585	0.00265	CbGpPWpGaD
Nafarelin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000584	0.000775	CcSEcCtD
Nafarelin—Nausea—Glyburide—type 2 diabetes mellitus	0.000583	0.000773	CcSEcCtD
Nafarelin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000583	0.000773	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000583	0.00264	CbGpPWpGaD
Nafarelin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000581	0.000771	CcSEcCtD
Nafarelin—Asthenia—Orlistat—type 2 diabetes mellitus	0.000574	0.000762	CcSEcCtD
Nafarelin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000573	0.00076	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000571	0.00258	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.00057	0.00258	CbGpPWpGaD
Nafarelin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00057	0.000755	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000568	0.00257	CbGpPWpGaD
Nafarelin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000566	0.000751	CcSEcCtD
Nafarelin—Oedema—Ramipril—type 2 diabetes mellitus	0.000562	0.000745	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000561	0.00254	CbGpPWpGaD
Nafarelin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000561	0.000743	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.00056	0.00253	CbGpPWpGaD
Nafarelin—Constipation—Losartan—type 2 diabetes mellitus	0.00056	0.000743	CcSEcCtD
Nafarelin—Rash—Gliclazide—type 2 diabetes mellitus	0.000556	0.000737	CcSEcCtD
Nafarelin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000556	0.000736	CcSEcCtD
Nafarelin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000554	0.000735	CcSEcCtD
Nafarelin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000553	0.000733	CcSEcCtD
Nafarelin—Shock—Ramipril—type 2 diabetes mellitus	0.000553	0.000733	CcSEcCtD
Nafarelin—Headache—Gliclazide—type 2 diabetes mellitus	0.000552	0.000732	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000549	0.00248	CbGpPWpGaD
Nafarelin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000548	0.000726	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.000544	0.00246	CbGpPWpGaD
Nafarelin—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000543	0.00072	CcSEcCtD
Nafarelin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000536	0.00071	CcSEcCtD
Nafarelin—Anorexia—Ramipril—type 2 diabetes mellitus	0.000536	0.00071	CcSEcCtD
Nafarelin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000529	0.000702	CcSEcCtD
Nafarelin—Asthenia—Metformin—type 2 diabetes mellitus	0.000529	0.000702	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000529	0.00239	CbGpPWpGaD
Nafarelin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000524	0.000694	CcSEcCtD
Nafarelin—Pruritus—Metformin—type 2 diabetes mellitus	0.000522	0.000692	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000522	0.00236	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	0.000521	0.00235	CbGpPWpGaD
Nafarelin—Urticaria—Losartan—type 2 diabetes mellitus	0.000521	0.00069	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000519	0.00235	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000518	0.00234	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000516	0.00233	CbGpPWpGaD
Nafarelin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000515	0.000683	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000512	0.000679	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000511	0.00231	CbGpPWpGaD
Nafarelin—Rash—Valsartan—type 2 diabetes mellitus	0.000511	0.000677	CcSEcCtD
Nafarelin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00051	0.000677	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000509	0.0023	CbGpPWpGaD
Nafarelin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000509	0.000675	CcSEcCtD
Nafarelin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000508	0.000674	CcSEcCtD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000508	0.0023	CbGpPWpGaD
Nafarelin—Headache—Valsartan—type 2 diabetes mellitus	0.000508	0.000673	CcSEcCtD
Nafarelin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000505	0.000669	CcSEcCtD
Nafarelin—Rash—Orlistat—type 2 diabetes mellitus	0.000505	0.000669	CcSEcCtD
Nafarelin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000505	0.000669	CcSEcCtD
Nafarelin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000504	0.000669	CcSEcCtD
Nafarelin—Headache—Orlistat—type 2 diabetes mellitus	0.000502	0.000665	CcSEcCtD
Nafarelin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000501	0.000664	CcSEcCtD
Nafarelin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.0005	0.000662	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000499	0.00226	CbGpPWpGaD
Nafarelin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000493	0.000653	CcSEcCtD
Nafarelin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000488	0.000648	CcSEcCtD
Nafarelin—Dizziness—Metformin—type 2 diabetes mellitus	0.000488	0.000647	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000485	0.00219	CbGpPWpGaD
Nafarelin—Nausea—Valsartan—type 2 diabetes mellitus	0.000481	0.000638	CcSEcCtD
Nafarelin—Constipation—Ramipril—type 2 diabetes mellitus	0.00048	0.000637	CcSEcCtD
Nafarelin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000476	0.000632	CcSEcCtD
Nafarelin—Nausea—Orlistat—type 2 diabetes mellitus	0.000476	0.00063	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000472	0.00213	CbGpPWpGaD
Nafarelin—Asthenia—Losartan—type 2 diabetes mellitus	0.00047	0.000623	CcSEcCtD
Nafarelin—Vomiting—Metformin—type 2 diabetes mellitus	0.000469	0.000622	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.000467	0.00211	CbGpPWpGaD
Nafarelin—Rash—Metformin—type 2 diabetes mellitus	0.000465	0.000617	CcSEcCtD
Nafarelin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000465	0.000616	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000464	0.0021	CbGpPWpGaD
Nafarelin—Pruritus—Losartan—type 2 diabetes mellitus	0.000464	0.000615	CcSEcCtD
Nafarelin—Headache—Metformin—type 2 diabetes mellitus	0.000462	0.000613	CcSEcCtD
Nafarelin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00046	0.00061	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000451	0.00204	CbGpPWpGaD
Nafarelin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000448	0.000594	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000448	0.00202	CbGpPWpGaD
Nafarelin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000446	0.000592	CcSEcCtD
Nafarelin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000443	0.000587	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000442	0.002	CbGpPWpGaD
Nafarelin—Rash—Irbesartan—type 2 diabetes mellitus	0.000439	0.000582	CcSEcCtD
Nafarelin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000439	0.000582	CcSEcCtD
Nafarelin—Nausea—Metformin—type 2 diabetes mellitus	0.000438	0.000581	CcSEcCtD
Nafarelin—Headache—Irbesartan—type 2 diabetes mellitus	0.000436	0.000578	CcSEcCtD
Nafarelin—Dizziness—Losartan—type 2 diabetes mellitus	0.000433	0.000574	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00042	0.0019	CbGpPWpGaD
Nafarelin—Vomiting—Losartan—type 2 diabetes mellitus	0.000417	0.000552	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000416	0.00188	CbGpPWpGaD
Nafarelin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000414	0.000548	CcSEcCtD
Nafarelin—Rash—Losartan—type 2 diabetes mellitus	0.000413	0.000548	CcSEcCtD
Nafarelin—Dermatitis—Losartan—type 2 diabetes mellitus	0.000413	0.000547	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000413	0.00187	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000413	0.00187	CbGpPWpGaD
Nafarelin—Headache—Losartan—type 2 diabetes mellitus	0.00041	0.000544	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000407	0.00184	CbGpPWpGaD
Nafarelin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000403	0.000534	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000402	0.00182	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000402	0.00182	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000401	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000401	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	0.0004	0.00181	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000399	0.0018	CbGpPWpGaD
Nafarelin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000398	0.000527	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000396	0.00179	CbGpPWpGaD
Nafarelin—Nausea—Losartan—type 2 diabetes mellitus	0.000389	0.000516	CcSEcCtD
Nafarelin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000384	0.00051	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000381	0.00172	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.000376	0.0017	CbGpPWpGaD
Nafarelin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000372	0.000493	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000367	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000362	0.00164	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000358	0.00162	CbGpPWpGaD
Nafarelin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000357	0.000474	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000356	0.00161	CbGpPWpGaD
Nafarelin—Rash—Ramipril—type 2 diabetes mellitus	0.000354	0.00047	CcSEcCtD
Nafarelin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000354	0.000469	CcSEcCtD
Nafarelin—GNRHR—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000354	0.0016	CbGpPWpGaD
Nafarelin—Headache—Ramipril—type 2 diabetes mellitus	0.000352	0.000467	CcSEcCtD
Nafarelin—GNRHR—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000349	0.00158	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000348	0.00157	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000347	0.00157	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000346	0.00156	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000341	0.00154	CbGpPWpGaD
Nafarelin—Nausea—Ramipril—type 2 diabetes mellitus	0.000334	0.000442	CcSEcCtD
Nafarelin—GNRHR—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000333	0.00151	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000331	0.0015	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000322	0.00146	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000321	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000321	0.00145	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000317	0.00143	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000313	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000311	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000311	0.00141	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000306	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000305	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000305	0.00138	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000301	0.00136	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000293	0.00132	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000283	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000282	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000279	0.00126	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000279	0.00126	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000274	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000273	0.00124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000261	0.00118	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000256	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000256	0.00116	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000242	0.0011	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.00024	0.00109	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000237	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000237	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000236	0.00107	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000235	0.00106	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000232	0.00105	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000229	0.00104	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000228	0.00103	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000225	0.00102	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000219	0.000989	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000214	0.000968	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000205	0.000928	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000201	0.000911	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—C3—type 2 diabetes mellitus	0.000197	0.00089	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000188	0.000849	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000187	0.000847	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000187	0.000846	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000184	0.000832	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000183	0.000829	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000183	0.000829	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000181	0.000819	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000173	0.000782	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000164	0.000739	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—INS—type 2 diabetes mellitus	0.000157	0.000708	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000154	0.000697	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000151	0.000685	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000151	0.000684	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000151	0.000681	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000144	0.00065	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000137	0.000621	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000137	0.000621	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000129	0.000584	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000118	0.000532	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000117	0.000527	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.000116	0.000524	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.00011	0.000498	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	0.000109	0.000493	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—type 2 diabetes mellitus	0.000107	0.000483	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SRC—type 2 diabetes mellitus	0.000102	0.000459	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.89e-05	0.000447	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.08e-05	0.000411	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.9e-05	0.000403	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—type 2 diabetes mellitus	6.84e-05	0.000309	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.31e-05	0.000285	CbGpPWpGaD
